DEFINITION of Barrett's esophagus

Barrett’s esophagus is a serious complication of Gastroesophageal Reflux Disease (GERD). In this condition, the stratified squamous epithelium that normally lines the distal esophagus undergoes metaplasia, transforming into specialized intestinal-type columnar epithelium containing goblet cells. This change is an adaptive response to chronic injury from gastric acid and bile reflux.

  • Diagnosis: Requires endoscopic visualization of salmon-colored mucosa extending at least 1 cm above the gastroesophageal junction (GEJ), confirmed by biopsy showing intestinal metaplasia (goblet cells).
  • Significance: It is the only known precursor lesion for esophageal adenocarcinoma. Patients are monitored via surveillance endoscopy to detect dysplasia (low-grade or high-grade) or early cancer.
  • Classification: Often classified by the length of the segment (Short-segment <3 cm; Long-segment ≥3 cm) using the Prague C & M criteria.

ETYMOLOGY of Barrett's esophagus

greek Named after Norman Barrett (1903-1979), an Australian-born British thoracic surgeon.

  • In 1950, Barrett described the condition, originally believing it was a congenital shortening of the esophagus where the stomach had pulled up into the chest (“short esophagus”).
  • It was later clarified by other researchers (notably Allison and Johnstone) that the condition was actually an acquired metaplastic change due to reflux, but the eponym “Barrett’s esophagus” remained.
  • The term combines the proper noun Barrett + esophagus (from Greek oisophagos, meaning “gullet” or “carrier of food”).

RELATED TERMS

  • GERD (Gastroesophageal Reflux Disease): The primary causative factor; chronic acid reflux leads to the tissue changes.
  • Metaplasia: The reversible replacement of one adult cell type by another adult cell type (squamous to columnar).
  • dysplasia: Abnormal cell growth within the Barrett’s tissue; a precancerous stage categorized as Low-Grade Dysplasia (LGD) or High-Grade Dysplasia (HGD).
  • Adenocarcinoma: The type of cancer that arises from Barrett’s esophagus.
  • Squamous Cell Carcinoma: A different type of esophageal cancer (usually linked to smoking/alcohol) that arises from the normal squamous lining, not Barrett’s.
  • Radiofrequency Ablation (RFA): A common endoscopic treatment used to destroy Barrett’s tissue (e.g., HALO system).
  • Prague C & M Criteria: The standard endoscopic grading system (C = Circumferential extent, M = Maximum extent).

CODING AND NUANCES

ICD-10-CM Codes Note: Specificity regarding the presence of dysplasia is critical for coding Barrett’s Esophagus.

Without dysplasia

  • K22.70-: Barrett’s esophagus without dysplasia

With Dysplasia

  • K22.71-: Barrett’s esophagus with low grade dysplasia
  • K22.72-: Barrett’s esophagus with high grade dysplasia
  • K22.710: Barrett’s esophagus with indefinite for dysplasia (Note: Some coding systems map “indefinite” to low grade or unspecified depending on guidelines, but K22.71 is often used for LGD. If “indefinite” is explicitly documented, check current year guidelines; often coded as K22.70- or K22.71- depending on payer, but strictly speaking, there isn’t a unique 6th character for “indefinite” in the base K22.7 list, so it often defaults to K22.70 or K22.71 based on physician intent. However, the official 2024/2026 code set includes:)
    • Correction: The specific codes are:
    • K22.70-: Barrett’s esophagus without dysplasia
    • K22.71-: Barrett’s esophagus with low grade dysplasia
    • K22.72-: Barrett’s esophagus with high grade dysplasia
    • (If documented as “indefinite for dysplasia,” it is typically coded as K22.70 [without dysplasia] unless the provider indicates it should be managed as low grade, but strict coding rules usually default “indefinite” to the lower severity category i.e., without dysplasia).

Associated Code for GERD (if concurrent)

  • K21.0: Gastro-esophageal reflux disease with esophagitis
  • K21.9: Gastro-esophageal reflux disease without esophagitis

CPT Codes CPT codes depend on the procedure performed (diagnostic vs. therapeutic).

Diagnostic Procedures

  • 43235: Esophagogastroduodenoscopy (EGD), flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure). Used for initial diagnosis and surveillance biopsies.
  • 43239: EGD with biopsy, single or multiple. Often billed if biopsies are the primary focus, though 43235 includes brushing/washing; specific biopsy coding rules apply. (Note: 43235 is the comprehensive diagnostic code often used for Barrett’s surveillance).

Therapeutic Procedures (Ablation/Resection)

  • 43216: Esophagoscopy, flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique. Sometimes used for focal ablation.
  • 43228: Esophagoscopy, flexible, transoral; with thermal ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed). Commonly used for Radiofrequency Ablation (RFA) of Barrett’s.
  • 43257: Esophagogastroduodenoscopy, flexible, transoral; with endoscopic mucosal resection (EMR). Used for removing visible nodules or areas of high-grade dysplasia/early cancer within the Barrett’s segment.
  • 43258: … with endoscopic submucosal dissection (ESD). Advanced technique for en-bloc resection of large lesions.

Other Related CPTs

  • 43236: EGD with insertion of guide wire followed by dilation of esophagus (over guide wire). If stricture dilation is needed alongside Barrett’s management.


Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms